Power and Precision with Plus Therapeutics

In this insightful episode of The Glioblastoma AKA GBM Podcast, we're joined by Dr. Marc Hedrick, President and CEO of Plus Therapeutics. Dr. Hedrick brings his extensive background in surgery and regenerative medicine to discuss the forefront of cancer treatment—targeted radiotherapeutics. He delves into the exciting developments of the ReSPECT GBM clinical trial, addressing the challenges and innovative approaches to treating recurrent glioblastoma, a notoriously difficult condition to manage. Listen in as Dr. Hedrick shares his unique insights on the potential of new therapies and the future of glioblastoma treatment. Trigger Warning: This episode includes discussions on medical conditions, cancer treatments, and clinical trials. For more information and support resources, visit GBMResearch.org. Episode Sponsor: Plus Therapeutics. Visit https://plustherapeutics.com/for-patients/ to learn more. Disclaimer: The content discussed on The Glioblastoma AKA GBM Podcast is based on personal stories and experiences. It is not intended as medical advice. Always consult with healthcare professionals for medical guidance and treatment options.